Abstract B138: Biocompatible, injectable, and thermoresponsive nanoparticle-loaded hydrogel for the controlled release of FGFR irreversible inhibitor-1 of pancreatic perineural invasion
Pancreatic ductal adenocarcinoma (PDAC) is characterized by an aggressive microenvironment and a pronounced tendency for perineural invasion (PI), which worsens prognosis and contributes to pain and local recurrence [1]. Local controlled drug delivery may improve therapeutic outcomes while reducing systemic toxicity...